Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for prevention of HE after TIPS
NCT01559519Phase 4Completed
- Sponsor
- Sapienza University of Rome
- Start
- Sep 2012
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of albumin (human) in hepatic encephalopathy (HE), sponsored by Sapienza University of Rome. Started Sep 2012; status: completed.
02
Drugs
albumin (human)
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT01559519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01559519.